CClinicalTrials.gg
CompletedNCT05811026Updated Jun 18, 2025Results posted

Efficacy of Periorbital Rejuvenation With a 1927 nm Diode Laser Treatment

An interventional study of Periorbital rejuvenation with a 1927 nm diode laser treatment (2-week interval) and Periorbital rejuvenation with a 1927 nm diode laser treatment (4-week interval) in Laser and Periorbital, sponsored by National Taiwan University Hospital. Completed at 1 site in Taiwan. Open to participants aged 30 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-18.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
30 Years to 65 Years
Sex
All
01

Study summary

The purpose of this research project is to investigate the treatment design, therapeutic effects and safety of the 1927 nm laser for the rejuvenation of the skin around the eyes.

Read the detailed description

The chromophore of the 1927 nm diode laser is mainly water, which can be used for skin rejuvenation. This study intends to use the Solta CLEAR+BRILLIANT Laser System, featuring a 1927 nm diode laser with 5 mJ energy, a treatment spot of 140 μm, a treatment depth of 170 μm, and a treatment coverage of approximately 5% per energy level after four rounds of treatment using the patented Intelligent Optical Tracking® System (IOTs). The purpose of this research project is to investigate the treatment design, therapeutic effects and safety of the 1927 nm laser for the rejuvenation of the skin around the eyes. This is an open-label, single-center clinical trial. Participants will be randomized into treatment groups, including Group A (treatment interval of 2 weeks) or Group B (treatment interval of 4 weeks).

02

Conditions studied

  • Laser
  • Periorbital

Keywords

  • 1927 nm
  • periorbital rejuvenation
03

In context

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. aged between 30 and 65 years old;
  2. no significant skin lesions or inflammation on the facial skin;
  3. willing and able to comply with study requirements, instructions, and restrictions;
  4. signed informed consent form.

Exclusion criteria

Exclusion Criteria:

  1. underwent facial active treatment, such as using laser, intense pulsed light, radiofrequency skin tightening, ultrasound skin tightening, botulinum toxin, or dermal fillers injection, within the previous six months;
  2. have chronic skin diseases such as atopic dermatitis, psoriasis, chronic urticaria, vitiligo, rosacea, or keloid;
  3. pregnant or breastfeeding;
  4. suffered from acute illnesses or infections requiring treatment within 14 days before entering the study;
  5. have had serious illnesses (such as heart disease, lung disease, brain disease, or liver disease) within the previous three months;
  6. allergic to Lidocaine or Prilocaine used in topical anesthetic cream or suffer from methemoglobinemia;
  7. used any skin medication on the face within 30 days before the trial, deemed by the principal investigator to affect the study results;
  8. deemed unsuitable for the study by the principal investigator.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Arm A: 2-week interval between treatments

    The interval between the first, second, and third treatments in this arm is two weeks, and the follow-up session will take place four weeks after the third treatment.

    Device: Periorbital rejuvenation with a 1927 nm diode laser treatment (2-week interval)

  • Experimental
    Arm B: 4-week interval between treatments

    The interval between the first, second, and third treatments in this arm is four weeks, and the follow-up session will take place four weeks after the third treatment.

    Device: Periorbital rejuvenation with a 1927 nm diode laser treatment (4-week interval)

Interventions

  • DevicePeriorbital rejuvenation with a 1927 nm diode laser treatment (2-week interval)

    * Visit 1 (W0): Clear + Brilliant™ Permea device periorbital treatment * Visit 2 (W2): Clear + Brilliant™ Permea device periorbital treatment * Visit 3 (W4): Clear + Brilliant™ Permea device periorbital treatment * Visit 4 (W8): Four weeks after the third treatment, a follow-up assessment will be performed

  • DevicePeriorbital rejuvenation with a 1927 nm diode laser treatment (4-week interval)

    * Visit 1 (W0): Clear + Brilliant™ Permea device periorbital treatment * Visit 2 (W4): Clear + Brilliant™ Permea device periorbital treatment * Visit 3 (W8): Clear + Brilliant™ Permea device periorbital treatment * Visit 4 (W12): Four weeks after the third treatment, a follow-up assessment will be performed

06

What researchers measure

Primary outcomes

  1. Change From Baseline in Texture Score at Visit 4 (End-of-study Session)

    The texture score is a parameter measured by the Antera 3D system, calculated based on average roughness (Ra \[μm\]). Ra roughness, or average roughness, is a standard metric used to describe surface smoothness. It represents the average height of microscopic peaks and valleys on the skin surface. The Ra \[μm\] values range from 0 to infinity. To interpret the texture score, skin surface roughness is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate poorer skin texture. The overall texture score ranges from 0 to infinity. Change from baseline in texture score at Visit 4 = texture score at Visit 4 - texture score at baseline

    Time frame: Group A: baseline and week 8; Group B: baseline and week 12

Secondary outcomes

  1. Change From Baseline in Color Measurements (L*) at Visit 4 (End-of-study Session)

    In the CIELAB color space, the L\* value represents the lightness of a color, indicating how light or dark it appears. The scale ranges from 0 (black) to 100 (white), providing a standardized measure of brightness that aligns with human visual perception. This metric is particularly useful in assessing skin tone. The average L\* value within a region of interest was calculated at each visit. Change from baseline in L\* at Visit 4 = L\* at Visit 4 - L\* at baseline

    Time frame: Group A: baseline and week 8; Group B: baseline and week 12

  2. Change From Baseline in Pigmentation Score at Visit 4 (End-of-study Session)

    The pigmentation score is a parameter measured by the Antera 3D system, calculated based on the variation (arbitrary units) and average level (arbitrary units). Variation (arbitrary units) indicates mean value within the region of interest of all deviations from the pigmentation average level in absolute value. Average level (arbitrary units) indicates the average concentration of pigmentation in the region of interest. To interpret the pigmentation score, skin pigmentation is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate poorer pigmentation conditions. The overall pigmentation score ranges from 0 to infinity. Change from baseline in pigmentation score at Visit 4 = pigmentation score at Visit 4 - pigmentation score at baseline

    Time frame: Group A: baseline and week 8; Group B: baseline and week 12

  3. Change From Baseline in Pores' Index at Visit 4 (End-of-study Session)

    The pores' index is an overall score representing skin porosity within the selected region of interest. It incorporates pore depth, size, and density-condensed into a single parameter. This index is particularly useful for the global evaluation of porosity reduction in before-and-after comparisons. Formula: Index = (V / S) × 1000 V = total volume of pores in the selected area (mm³) S = selected area (mm²) Change from baseline in pores' index at Visit 4 = pores' index at Visit 4-pores' indexe at baseline

    Time frame: Group A: baseline and week 8; Group B: baseline and week 12

  4. Change From Baseline in Wrinkles' Score at Visit 4 (End-of-study Session)

    The wrinkle score is a parameter measured by the Antera 3D system, calculated based on the indentation index (μm). The indentation index (μm) represents the average depth of all points or dents below the surface level. The indentation index (μm) values range from 0 to infinity. To interpret the wrinkle score, skin damage is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate more severe wrinkle conditions. The overall wrinkle score ranges from 0 to infinity. Change from baseline in wrinkles' score at Visit 4 = wrinkles' score at Visit 4 - wrinkles' score at baseline

    Time frame: Group A: baseline and week 8; Group B: baseline and week 12

  5. Change From Baseline in Physician Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 4 (End-of-study Session)

    Global Aesthetic Improvement Score (GAIS) is a standardized 5-point scale used to assess overall aesthetic improvement following a cosmetic treatment. It ranges as follows: 5 - Very Much Improved, 4 - Much Improved, 3 - Improved, 2 - No Change, 1 - Worse Physician Assessment of GAIS refers to the GAIS score evaluated by the physician. Change from Baseline in Physician Assessment of GAIS at Visit 4 is defined as the GAIS score assessed at Visit 4 in comparison to baseline.

    Time frame: Group A: baseline and week 8; Group B: baseline and week 12

  6. Change From Baseline in Patient Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 4 (End-of-study Session)

    Global Aesthetic Improvement Score (GAIS) is a standardized 5-point scale used to assess overall aesthetic improvement following a cosmetic treatment. It ranges as follows: 5 - Very Much Improved, 4 - Much Improved, 3 - Improved, 2 - No Change, 1 - Worse Patient Assessment of GAIS refers to the GAIS score evaluated by the patient. Change from Baseline in Patient Assessment of GAIS at Visit 4 is defined as the GAIS score assessed at Visit 4 in comparison to baseline.

    Time frame: Group A: baseline and week 8; Group B: baseline and week 12

  7. Change From Baseline in Texture Score at Visit 2

    The texture score is a parameter measured by the Antera 3D system, calculated based on average roughness (Ra \[μm\]). Ra roughness, or average roughness, is a standard metric used to describe surface smoothness. It represents the average height of microscopic peaks and valleys on the skin surface. The Ra \[μm\] values range from 0 to infinity. To interpret the texture score, skin surface roughness is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate poorer skin texture. The overall texture score ranges from 0 to infinity. Change from baseline in texture score at Visit 2 = texture score at Visit 2 - texture score at baseline

    Time frame: Group A: baseline and week 2; Group B: baseline and week 4

  8. Change From Baseline in Color Measurements (L*) at Visit 2

    In the CIELAB color space, the L\* value represents the lightness of a color, indicating how light or dark it appears. The scale ranges from 0 (black) to 100 (white), providing a standardized measure of brightness that aligns with human visual perception. This metric is particularly useful in assessing skin tone. The average L\* value within a region of interest was calculated at each visit. Change from baseline in L\* at Visit 2 = L\* at Visit 2 - L\* at baseline

    Time frame: Group A: baseline and week 2; Group B: baseline and week 4

  9. Change From Baseline in Pigmentation Score at Visit 2

    The pigmentation score is a parameter measured by the Antera 3D system, calculated based on the variation (arbitrary units) and average level (arbitrary units). Variation (arbitrary units) indicates mean value within the region of interest of all deviations from the pigmentation average level in absolute value. Average level (arbitrary units) indicates the average concentration of pigmentation in the region of interest. To interpret the pigmentation score, skin pigmentation is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate poorer pigmentation conditions. The overall pigmentation score ranges from 0 to infinity. Change from baseline in pigmentation score at Visit 2 = pigmentation score at Visit 2 - pigmentation score at baseline

    Time frame: Group A: baseline and week 2; Group B: baseline and week 4

  10. Change From Baseline in Pores' Index at Visit 2

    The pores' index is an overall score representing skin porosity within the selected region of interest. It incorporates pore depth, size, and density-condensed into a single parameter. This index is particularly useful for the global evaluation of porosity reduction in before-and-after comparisons. Formula: Index = (V / S) × 1000 V = total volume of pores in the selected area (mm³) S = selected area (mm²) Change from baseline in pores' index at Visit 2 = pores' index at Visit 2 - pores' index at baseline

    Time frame: Group A: baseline and week 2; Group B: baseline and week 4

  11. Change From Baseline in Wrinkles' Score at Visit 2

    The wrinkle score is a parameter measured by the Antera 3D system, calculated based on the indentation index (μm). The indentation index (μm) represents the average depth of all points or dents below the surface level. The indentation index (μm) values range from 0 to infinity. To interpret the wrinkle score, skin damage is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate more severe wrinkle conditions. The overall wrinkle score ranges from 0 to infinity. Change from baseline in wrinkles' score at Visit 2 = wrinkles' score at Visit 2 - wrinkles' score at baseline

    Time frame: Group A: baseline and week 2; Group B: baseline and week 4

  12. Change From Baseline in Physician Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 2

    Global Aesthetic Improvement Score (GAIS) is a standardized 5-point scale used to assess overall aesthetic improvement following a cosmetic treatment. It ranges as follows: 5 - Very Much Improved, 4 - Much Improved, 3 - Improved, 2 - No Change, 1 - Worse Physician Assessment of GAIS refers to the GAIS score evaluated by the physician. Change from Baseline in Physician Assessment of GAIS at Visit 2 is defined as the GAIS score assessed at Visit 2 in comparison to baseline.

    Time frame: Group A: baseline and week 2; Group B: baseline and week 4

  13. Change From Baseline in Patient Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 2

    Global Aesthetic Improvement Score (GAIS) is a standardized 5-point scale used to assess overall aesthetic improvement following a cosmetic treatment. It ranges as follows: 5 - Very Much Improved, 4 - Much Improved, 3 - Improved, 2 - No Change, 1 - Worse Patient Assessment of GAIS refers to the GAIS score evaluated by the patient. Change from Baseline in Patient Assessment of GAIS at Visit 2 is defined as the GAIS score assessed at Visit 2 in comparison to baseline.

    Time frame: Group A: baseline and week 2; Group B: baseline and week 4

  14. Change From Baseline in Texture Score at Visit 3

    The texture score is a parameter measured by the Antera 3D system, calculated based on average roughness (Ra \[μm\]). Ra roughness, or average roughness, is a standard metric used to describe surface smoothness. It represents the average height of microscopic peaks and valleys on the skin surface. The Ra \[μm\] values range from 0 to infinity. To interpret the texture score, skin surface roughness is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate poorer skin texture. The overall texture score ranges from 0 to infinity. Change from baseline in texture score at Visit 3 = texture score at Visit 3 - texture score at baseline

    Time frame: Group A: baseline and week 4; Group B: baseline and week 8

  15. Change From Baseline in Color Measurements (L*) at Visit 3

    In the CIELAB color space, the L\* value represents the lightness of a color, indicating how light or dark it appears. The scale ranges from 0 (black) to 100 (white), providing a standardized measure of brightness that aligns with human visual perception. This metric is particularly useful in assessing skin tone. The average L\* value within a region of interest was calculated at each visit. Change from baseline in L\* at Visit 3 = L\* at Visit 3 - L\* at baseline

    Time frame: Group A: baseline and week 4; Group B: baseline and week 8

  16. Change From Baseline in Pigmentation Score at Visit 3

    The pigmentation score is a parameter measured by the Antera 3D system, calculated based on the variation (arbitrary units) and average level (arbitrary units). Variation (arbitrary units) indicates mean value within the region of interest of all deviations from the pigmentation average level in absolute value. Average level (arbitrary units) indicates the average concentration of pigmentation in the region of interest. To interpret the pigmentation score, skin pigmentation is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate poorer pigmentation conditions. The overall pigmentation score ranges from 0 to infinity. Change from baseline in pigmentation score at Visit 3 = pigmentation score at Visit 3 - pigmentation score at baseline

    Time frame: Group A: baseline and week 4; Group B: baseline and week 8

  17. Change From Baseline in Pores' Index at Visit 3

    The pores' index is an overall score representing skin porosity within the selected region of interest. It incorporates pore depth, size, and density-condensed into a single parameter. This index is particularly useful for the global evaluation of porosity reduction in before-and-after comparisons. Formula: Index = (V / S) × 1000 V = total volume of pores in the selected area (mm³) S = selected area (mm²) Change from baseline in pores' index at Visit 3 = pores' index at Visit 3 - pores' index at baseline

    Time frame: Group A: baseline and week 4; Group B: baseline and week 8

  18. Change From Baseline in Wrinkles' Score at Visit 3

    The wrinkle score is a parameter measured by the Antera 3D system, calculated based on the indentation index (μm). The indentation index (μm) represents the average depth of all points or dents below the surface level. The indentation index (μm) values range from 0 to infinity. To interpret the wrinkle score, skin damage is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate more severe wrinkle conditions. The overall wrinkle score ranges from 0 to infinity. Change from baseline in wrinkles' score at Visit 3 = wrinkles' score at Visit 3 - wrinkles' score at baseline

    Time frame: Group A: baseline and week 4; Group B: baseline and week 8

  19. Change From Baseline in Physician Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 3

    Global Aesthetic Improvement Score (GAIS) is a standardized 5-point scale used to assess overall aesthetic improvement following a cosmetic treatment. It ranges as follows: 5 - Very Much Improved, 4 - Much Improved, 3 - Improved, 2 - No Change, 1 - Worse Physician Assessment of GAIS refers to the GAIS score evaluated by the physician. Change from Baseline in Physician Assessment of GAIS at Visit 3 is defined as the GAIS score assessed at Visit 3 in comparison to baseline.

    Time frame: Group A: baseline and week 4; Group B: baseline and week 8

  20. Change From Baseline in Patient Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 3

    Global Aesthetic Improvement Score (GAIS) is a standardized 5-point scale used to assess overall aesthetic improvement following a cosmetic treatment. It ranges as follows: 5 - Very Much Improved, 4 - Much Improved, 3 - Improved, 2 - No Change, 1 - Worse Patient Assessment of GAIS refers to the GAIS score evaluated by the patient. Change from Baseline in Patient Assessment of GAIS at Visit 3 is defined as the GAIS score assessed at Visit 3 in comparison to baseline.

    Time frame: Group A: baseline and week 4; Group B: baseline and week 8

  21. Visual Analogue Scale (VAS) During Treatment

    The visual analogue scale (VAS) is a psychometric response scale that can be used in questionnaires, which a higher score suggests greater pain intensity. It ranges from 0 to 10 in increments of 1. A score of 0 cm indicates "no pain" and 10 indicates "worst pain imaginable".

    Time frame: Group A: week 0; Group B: week 0

07

Results

Posted Jun 18, 2025

Participant flow

Participant flow — Overall Study
MilestoneArm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between Treatments
Started1010
Completed1010
Not completed00

Outcome measures

PrimaryChange From Baseline in Texture Score at Visit 4 (End-of-study Session)

The texture score is a parameter measured by the Antera 3D system, calculated based on average roughness (Ra \[μm\]). Ra roughness, or average roughness, is a standard metric used to describe surface smoothness. It represents the average height of microscopic peaks and valleys on the skin surface. The Ra \[μm\] values range from 0 to infinity. To interpret the texture score, skin surface roughness is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate poorer skin texture. The overall texture score ranges from 0 to infinity. Change from baseline in texture score at Visit 4 = texture score at Visit 4 - texture score at baseline

Time frame:
Group A: baseline and week 8; Group B: baseline and week 12
Reported as:
Median · score on a scale
Change From Baseline in Texture Score at Visit 4 (End-of-study Session)
score on a scaleArm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between Treatments
Change From Baseline in Texture Score at Visit 4 (End-of-study Session)0.25 (-0.375 to 7.125)-4.75 (-7.25 to -0.5)
Statistical analysis
  • Arm A: 2-week Interval Between Treatments vs Arm B: 4-week Interval Between Treatments · Wilcoxon (Mann-Whitney) · p = 0.075 (Statistical significance was defined as a p-value \< 0.05.) · Median difference (net): 5Differece = (2-week interval group) - (4-week interval group)
SecondaryChange From Baseline in Color Measurements (L*) at Visit 4 (End-of-study Session)

In the CIELAB color space, the L\* value represents the lightness of a color, indicating how light or dark it appears. The scale ranges from 0 (black) to 100 (white), providing a standardized measure of brightness that aligns with human visual perception. This metric is particularly useful in assessing skin tone. The average L\* value within a region of interest was calculated at each visit. Change from baseline in L\* at Visit 4 = L\* at Visit 4 - L\* at baseline

Time frame:
Group A: baseline and week 8; Group B: baseline and week 12
Reported as:
Median · score on a scale
Change From Baseline in Color Measurements (L*) at Visit 4 (End-of-study Session)
score on a scaleArm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between Treatments
Change From Baseline in Color Measurements (L*) at Visit 4 (End-of-study Session)-0.61495 (-1.0353375 to -0.119875)-0.798575 (-0.9895125 to -0.1737125)
Statistical analysis
  • Arm A: 2-week Interval Between Treatments vs Arm B: 4-week Interval Between Treatments · Wilcoxon (Mann-Whitney) · p = 0.4727 (Statistical significance was defined as a p-value \< 0.05.) · Median difference (net): 0.17Differece = (2-week interval group) - (4-week interval group)
SecondaryChange From Baseline in Pigmentation Score at Visit 4 (End-of-study Session)

The pigmentation score is a parameter measured by the Antera 3D system, calculated based on the variation (arbitrary units) and average level (arbitrary units). Variation (arbitrary units) indicates mean value within the region of interest of all deviations from the pigmentation average level in absolute value. Average level (arbitrary units) indicates the average concentration of pigmentation in the region of interest. To interpret the pigmentation score, skin pigmentation is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate poorer pigmentation conditions. The overall pigmentation score ranges from 0 to infinity. Change from baseline in pigmentation score at Visit 4 = pigmentation score at Visit 4 - pigmentation score at baseline

Time frame:
Group A: baseline and week 8; Group B: baseline and week 12
Reported as:
Median · score on a scale
Change From Baseline in Pigmentation Score at Visit 4 (End-of-study Session)
score on a scaleArm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between Treatments
Change From Baseline in Pigmentation Score at Visit 4 (End-of-study Session)-9 (-9.5 to -7)-7.5 (-10.375 to -4.75)
Statistical analysis
  • Arm A: 2-week Interval Between Treatments vs Arm B: 4-week Interval Between Treatments · Wilcoxon (Mann-Whitney) · p = 0.7326 (Statistical significance was defined as a p-value \< 0.05.) · Median difference (net): -1.5Differece = (2-week interval group) - (4-week interval group)
SecondaryChange From Baseline in Pores' Index at Visit 4 (End-of-study Session)

The pores' index is an overall score representing skin porosity within the selected region of interest. It incorporates pore depth, size, and density-condensed into a single parameter. This index is particularly useful for the global evaluation of porosity reduction in before-and-after comparisons. Formula: Index = (V / S) × 1000 V = total volume of pores in the selected area (mm³) S = selected area (mm²) Change from baseline in pores' index at Visit 4 = pores' index at Visit 4-pores' indexe at baseline

Time frame:
Group A: baseline and week 8; Group B: baseline and week 12
Reported as:
Median · score on a scale
Change From Baseline in Pores' Index at Visit 4 (End-of-study Session)
score on a scaleArm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between Treatments
Change From Baseline in Pores' Index at Visit 4 (End-of-study Session)-0.02675 (-0.1378625 to 0.2650375)-0.63555 (-0.8427125 to -0.1460625)
Statistical analysis
  • Arm A: 2-week Interval Between Treatments vs Arm B: 4-week Interval Between Treatments · Wilcoxon (Mann-Whitney) · p = 0.0757 (Statistical significance was defined as a p-value \< 0.05.) · Median difference (net): 0.61Differece = (2-week interval group) - (4-week interval group)
SecondaryChange From Baseline in Wrinkles' Score at Visit 4 (End-of-study Session)

The wrinkle score is a parameter measured by the Antera 3D system, calculated based on the indentation index (μm). The indentation index (μm) represents the average depth of all points or dents below the surface level. The indentation index (μm) values range from 0 to infinity. To interpret the wrinkle score, skin damage is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate more severe wrinkle conditions. The overall wrinkle score ranges from 0 to infinity. Change from baseline in wrinkles' score at Visit 4 = wrinkles' score at Visit 4 - wrinkles' score at baseline

Time frame:
Group A: baseline and week 8; Group B: baseline and week 12
Reported as:
Median · score on a scale
Change From Baseline in Wrinkles' Score at Visit 4 (End-of-study Session)
score on a scaleArm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between Treatments
Change From Baseline in Wrinkles' Score at Visit 4 (End-of-study Session)13 (-0.5 to 39)-29.75 (-48.75 to -11.375)
Statistical analysis
  • Arm A: 2-week Interval Between Treatments vs Arm B: 4-week Interval Between Treatments · Wilcoxon (Mann-Whitney) · p = 0.0376 (Statistical significance was defined as a p-value \< 0.05.) · Median difference (net): 37.75Differece = (2-week interval group) - (4-week interval group)
SecondaryChange From Baseline in Physician Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 4 (End-of-study Session)

Global Aesthetic Improvement Score (GAIS) is a standardized 5-point scale used to assess overall aesthetic improvement following a cosmetic treatment. It ranges as follows: 5 - Very Much Improved, 4 - Much Improved, 3 - Improved, 2 - No Change, 1 - Worse Physician Assessment of GAIS refers to the GAIS score evaluated by the physician. Change from Baseline in Physician Assessment of GAIS at Visit 4 is defined as the GAIS score assessed at Visit 4 in comparison to baseline.

Time frame:
Group A: baseline and week 8; Group B: baseline and week 12
Reported as:
Mean · score on a scale
Change From Baseline in Physician Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 4 (End-of-study Session)
score on a scaleArm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between Treatments
Change From Baseline in Physician Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 4 (End-of-study Session)2.8 (2.4 to 3.0)3.0 (2.7 to 3.3)
Statistical analysis
  • Arm A: 2-week Interval Between Treatments vs Arm B: 4-week Interval Between Treatments · Wilcoxon (Mann-Whitney) · p = 0.3123 (Statistical significance was defined as a p-value \< 0.05.) · Median difference (final values): -0.17Differece = (2-week interval group) - (4-week interval group)
SecondaryChange From Baseline in Patient Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 4 (End-of-study Session)

Global Aesthetic Improvement Score (GAIS) is a standardized 5-point scale used to assess overall aesthetic improvement following a cosmetic treatment. It ranges as follows: 5 - Very Much Improved, 4 - Much Improved, 3 - Improved, 2 - No Change, 1 - Worse Patient Assessment of GAIS refers to the GAIS score evaluated by the patient. Change from Baseline in Patient Assessment of GAIS at Visit 4 is defined as the GAIS score assessed at Visit 4 in comparison to baseline.

Time frame:
Group A: baseline and week 8; Group B: baseline and week 12
Reported as:
Median · score on a scale
Change From Baseline in Patient Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 4 (End-of-study Session)
score on a scaleArm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between Treatments
Change From Baseline in Patient Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 4 (End-of-study Session)3.0 (2.0 to 3.0)2.0 (2.0 to 2.0)
Statistical analysis
  • Arm A: 2-week Interval Between Treatments vs Arm B: 4-week Interval Between Treatments · Wilcoxon (Mann-Whitney) · p = 0.1009 (Statistical significance was defined as a p-value \< 0.05.) · Median difference (final values): 1Differece = (2-week interval group) - (4-week interval group)
SecondaryChange From Baseline in Texture Score at Visit 2

The texture score is a parameter measured by the Antera 3D system, calculated based on average roughness (Ra \[μm\]). Ra roughness, or average roughness, is a standard metric used to describe surface smoothness. It represents the average height of microscopic peaks and valleys on the skin surface. The Ra \[μm\] values range from 0 to infinity. To interpret the texture score, skin surface roughness is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate poorer skin texture. The overall texture score ranges from 0 to infinity. Change from baseline in texture score at Visit 2 = texture score at Visit 2 - texture score at baseline

Time frame:
Group A: baseline and week 2; Group B: baseline and week 4
Reported as:
Median · score on a scale
Change From Baseline in Texture Score at Visit 2
score on a scaleArm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between Treatments
Change From Baseline in Texture Score at Visit 21.5 (-1 to 5.375)-4 (-8 to -1.625)
Statistical analysis
  • Arm A: 2-week Interval Between Treatments vs Arm B: 4-week Interval Between Treatments · Wilcoxon (Mann-Whitney) · p = 0.0088 (Statistical significance was defined as a p-value \< 0.05.) · Mean difference (net): 5.5Differece = (2-week interval group) - (4-week interval group)
SecondaryChange From Baseline in Color Measurements (L*) at Visit 2

In the CIELAB color space, the L\* value represents the lightness of a color, indicating how light or dark it appears. The scale ranges from 0 (black) to 100 (white), providing a standardized measure of brightness that aligns with human visual perception. This metric is particularly useful in assessing skin tone. The average L\* value within a region of interest was calculated at each visit. Change from baseline in L\* at Visit 2 = L\* at Visit 2 - L\* at baseline

Time frame:
Group A: baseline and week 2; Group B: baseline and week 4
Reported as:
Median · score on a scale
Change From Baseline in Color Measurements (L*) at Visit 2
score on a scaleArm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between Treatments
Change From Baseline in Color Measurements (L*) at Visit 2-0.4711 (-0.6366375 to -0.0799375)-0.44215 (-0.5409375 to 0.5504)
Statistical analysis
  • Arm A: 2-week Interval Between Treatments vs Arm B: 4-week Interval Between Treatments · Wilcoxon (Mann-Whitney) · p = 0.4274 (Statistical significance was defined as a p-value \< 0.05.) · Median difference (net): -0.03Differece = (2-week interval group) - (4-week interval group)
SecondaryChange From Baseline in Pigmentation Score at Visit 2

The pigmentation score is a parameter measured by the Antera 3D system, calculated based on the variation (arbitrary units) and average level (arbitrary units). Variation (arbitrary units) indicates mean value within the region of interest of all deviations from the pigmentation average level in absolute value. Average level (arbitrary units) indicates the average concentration of pigmentation in the region of interest. To interpret the pigmentation score, skin pigmentation is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate poorer pigmentation conditions. The overall pigmentation score ranges from 0 to infinity. Change from baseline in pigmentation score at Visit 2 = pigmentation score at Visit 2 - pigmentation score at baseline

Time frame:
Group A: baseline and week 2; Group B: baseline and week 4
Reported as:
Median · score on a scale
Change From Baseline in Pigmentation Score at Visit 2
score on a scaleArm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between Treatments
Change From Baseline in Pigmentation Score at Visit 2-0.5 (-1.875 to 0.75)-2.25 (-5.25 to 1.5)
Statistical analysis
  • Arm A: 2-week Interval Between Treatments vs Arm B: 4-week Interval Between Treatments · Wilcoxon (Mann-Whitney) · p = 0.6497 (Statistical significance was defined as a p-value \< 0.05.) · Mean difference (net): 1.75Differece = (2-week interval group) - (4-week interval group)
SecondaryChange From Baseline in Pores' Index at Visit 2

The pores' index is an overall score representing skin porosity within the selected region of interest. It incorporates pore depth, size, and density-condensed into a single parameter. This index is particularly useful for the global evaluation of porosity reduction in before-and-after comparisons. Formula: Index = (V / S) × 1000 V = total volume of pores in the selected area (mm³) S = selected area (mm²) Change from baseline in pores' index at Visit 2 = pores' index at Visit 2 - pores' index at baseline

Time frame:
Group A: baseline and week 2; Group B: baseline and week 4
Reported as:
Median · score on a scale
Change From Baseline in Pores' Index at Visit 2
score on a scaleArm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between Treatments
Change From Baseline in Pores' Index at Visit 20.126725 (-0.169925 to 0.777575)-0.4088 (-0.6626875 to -0.3374875)
Statistical analysis
  • Arm A: 2-week Interval Between Treatments vs Arm B: 4-week Interval Between Treatments · Wilcoxon (Mann-Whitney) · p = 0.0006 (Statistical significance was defined as a p-value \< 0.05.) · Median difference (net): 0.54Differece = (2-week interval group) - (4-week interval group)
SecondaryChange From Baseline in Wrinkles' Score at Visit 2

The wrinkle score is a parameter measured by the Antera 3D system, calculated based on the indentation index (μm). The indentation index (μm) represents the average depth of all points or dents below the surface level. The indentation index (μm) values range from 0 to infinity. To interpret the wrinkle score, skin damage is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate more severe wrinkle conditions. The overall wrinkle score ranges from 0 to infinity. Change from baseline in wrinkles' score at Visit 2 = wrinkles' score at Visit 2 - wrinkles' score at baseline

Time frame:
Group A: baseline and week 2; Group B: baseline and week 4
Reported as:
Median · score on a scale
Change From Baseline in Wrinkles' Score at Visit 2
score on a scaleArm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between Treatments
Change From Baseline in Wrinkles' Score at Visit 211 (1.625 to 40.25)-23.5 (-43.125 to -17)
Statistical analysis
  • Arm A: 2-week Interval Between Treatments vs Arm B: 4-week Interval Between Treatments · Wilcoxon (Mann-Whitney) · p = 0.0002 (Statistical significance was defined as a p-value \< 0.05.) · Median difference (net): 34.5Differece = (2-week interval group) - (4-week interval group)
SecondaryChange From Baseline in Physician Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 2

Global Aesthetic Improvement Score (GAIS) is a standardized 5-point scale used to assess overall aesthetic improvement following a cosmetic treatment. It ranges as follows: 5 - Very Much Improved, 4 - Much Improved, 3 - Improved, 2 - No Change, 1 - Worse Physician Assessment of GAIS refers to the GAIS score evaluated by the physician. Change from Baseline in Physician Assessment of GAIS at Visit 2 is defined as the GAIS score assessed at Visit 2 in comparison to baseline.

Time frame:
Group A: baseline and week 2; Group B: baseline and week 4
Reported as:
Median · score on a scale
Change From Baseline in Physician Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 2
score on a scaleArm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between Treatments
Change From Baseline in Physician Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 24.0 (3.8 to 4.0)4.0 (3.7 to 4.0)
Statistical analysis
  • Arm A: 2-week Interval Between Treatments vs Arm B: 4-week Interval Between Treatments · Wilcoxon (Mann-Whitney) · p = 0.6231 (Statistical significance was defined as a p-value \< 0.05.) · Median difference (final values): 0Differece = (2-week interval group) - (4-week interval group)
SecondaryChange From Baseline in Patient Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 2

Global Aesthetic Improvement Score (GAIS) is a standardized 5-point scale used to assess overall aesthetic improvement following a cosmetic treatment. It ranges as follows: 5 - Very Much Improved, 4 - Much Improved, 3 - Improved, 2 - No Change, 1 - Worse Patient Assessment of GAIS refers to the GAIS score evaluated by the patient. Change from Baseline in Patient Assessment of GAIS at Visit 2 is defined as the GAIS score assessed at Visit 2 in comparison to baseline.

Time frame:
Group A: baseline and week 2; Group B: baseline and week 4
Reported as:
Median · score on a scale
Change From Baseline in Patient Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 2
score on a scaleArm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between Treatments
Change From Baseline in Patient Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 23.0 (3.0 to 4.0)3.0 (3.0 to 3.0)
Statistical analysis
  • Arm A: 2-week Interval Between Treatments vs Arm B: 4-week Interval Between Treatments · Wilcoxon (Mann-Whitney) · p = 0.3327 (Statistical significance was defined as a p-value \< 0.05.) · Median difference (final values): 0Differece = (2-week interval group) - (4-week interval group)
SecondaryChange From Baseline in Texture Score at Visit 3

The texture score is a parameter measured by the Antera 3D system, calculated based on average roughness (Ra \[μm\]). Ra roughness, or average roughness, is a standard metric used to describe surface smoothness. It represents the average height of microscopic peaks and valleys on the skin surface. The Ra \[μm\] values range from 0 to infinity. To interpret the texture score, skin surface roughness is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate poorer skin texture. The overall texture score ranges from 0 to infinity. Change from baseline in texture score at Visit 3 = texture score at Visit 3 - texture score at baseline

Time frame:
Group A: baseline and week 4; Group B: baseline and week 8
Reported as:
Median · score on a scale
Change From Baseline in Texture Score at Visit 3
score on a scaleArm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between Treatments
Change From Baseline in Texture Score at Visit 32.75 (-3.75 to 4.25)-4.5 (-8.5 to -3)
Statistical analysis
  • Arm A: 2-week Interval Between Treatments vs Arm B: 4-week Interval Between Treatments · Wilcoxon (Mann-Whitney) · p = 0.0752 (Statistical significance was defined as a p-value \< 0.05.) · Median difference (net): 7.25Differece = (2-week interval group) - (4-week interval group)
SecondaryChange From Baseline in Color Measurements (L*) at Visit 3

In the CIELAB color space, the L\* value represents the lightness of a color, indicating how light or dark it appears. The scale ranges from 0 (black) to 100 (white), providing a standardized measure of brightness that aligns with human visual perception. This metric is particularly useful in assessing skin tone. The average L\* value within a region of interest was calculated at each visit. Change from baseline in L\* at Visit 3 = L\* at Visit 3 - L\* at baseline

Time frame:
Group A: baseline and week 4; Group B: baseline and week 8
Reported as:
Median · score on a scale
Change From Baseline in Color Measurements (L*) at Visit 3
score on a scaleArm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between Treatments
Change From Baseline in Color Measurements (L*) at Visit 3-1.1979 (-1.744225 to -0.7522625)-0.26345 (-0.64905 to 0.0077)
Statistical analysis
  • Arm A: 2-week Interval Between Treatments vs Arm B: 4-week Interval Between Treatments · Wilcoxon (Mann-Whitney) · p = 0.0982 (Statistical significance was defined as a p-value \< 0.05.) · Median difference (net): -0.94Differece = (2-week interval group) - (4-week interval group)
SecondaryChange From Baseline in Pigmentation Score at Visit 3

The pigmentation score is a parameter measured by the Antera 3D system, calculated based on the variation (arbitrary units) and average level (arbitrary units). Variation (arbitrary units) indicates mean value within the region of interest of all deviations from the pigmentation average level in absolute value. Average level (arbitrary units) indicates the average concentration of pigmentation in the region of interest. To interpret the pigmentation score, skin pigmentation is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate poorer pigmentation conditions. The overall pigmentation score ranges from 0 to infinity. Change from baseline in pigmentation score at Visit 3 = pigmentation score at Visit 3 - pigmentation score at baseline

Time frame:
Group A: baseline and week 4; Group B: baseline and week 8
Reported as:
Median · score on a scale
Change From Baseline in Pigmentation Score at Visit 3
score on a scaleArm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between Treatments
Change From Baseline in Pigmentation Score at Visit 3-3 (-5.875 to -0.75)-2.5 (-5 to 0)
Statistical analysis
  • Arm A: 2-week Interval Between Treatments vs Arm B: 4-week Interval Between Treatments · Wilcoxon (Mann-Whitney) · p = 0.8541 (Statistical significance was defined as a p-value \< 0.05.) · Median difference (net): -0.5Differece = (2-week interval group) - (4-week interval group)
SecondaryChange From Baseline in Pores' Index at Visit 3

The pores' index is an overall score representing skin porosity within the selected region of interest. It incorporates pore depth, size, and density-condensed into a single parameter. This index is particularly useful for the global evaluation of porosity reduction in before-and-after comparisons. Formula: Index = (V / S) × 1000 V = total volume of pores in the selected area (mm³) S = selected area (mm²) Change from baseline in pores' index at Visit 3 = pores' index at Visit 3 - pores' index at baseline

Time frame:
Group A: baseline and week 4; Group B: baseline and week 8
Reported as:
Median · score on a scale
Change From Baseline in Pores' Index at Visit 3
score on a scaleArm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between Treatments
Change From Baseline in Pores' Index at Visit 30.299125 (-0.123325 to 0.41035)-0.33025 (-0.73005 to -0.1437)
Statistical analysis
  • Arm A: 2-week Interval Between Treatments vs Arm B: 4-week Interval Between Treatments · Wilcoxon (Mann-Whitney) · p = 0.0758 (Statistical significance was defined as a p-value \< 0.05.) · Median difference (net): 0.63Differece = (2-week interval group) - (4-week interval group)
SecondaryChange From Baseline in Wrinkles' Score at Visit 3

The wrinkle score is a parameter measured by the Antera 3D system, calculated based on the indentation index (μm). The indentation index (μm) represents the average depth of all points or dents below the surface level. The indentation index (μm) values range from 0 to infinity. To interpret the wrinkle score, skin damage is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate more severe wrinkle conditions. The overall wrinkle score ranges from 0 to infinity. Change from baseline in wrinkles' score at Visit 3 = wrinkles' score at Visit 3 - wrinkles' score at baseline

Time frame:
Group A: baseline and week 4; Group B: baseline and week 8
Reported as:
Median · score on a scale
Change From Baseline in Wrinkles' Score at Visit 3
score on a scaleArm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between Treatments
Change From Baseline in Wrinkles' Score at Visit 320.25 (-2.5 to 27)-21.5 (-36.5 to -21)
Statistical analysis
  • Arm A: 2-week Interval Between Treatments vs Arm B: 4-week Interval Between Treatments · Wilcoxon (Mann-Whitney) · p = 0.066 (Statistical significance was defined as a p-value \< 0.05.) · Median difference (net): 41.75Differece = (2-week interval group) - (4-week interval group)
SecondaryChange From Baseline in Physician Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 3

Global Aesthetic Improvement Score (GAIS) is a standardized 5-point scale used to assess overall aesthetic improvement following a cosmetic treatment. It ranges as follows: 5 - Very Much Improved, 4 - Much Improved, 3 - Improved, 2 - No Change, 1 - Worse Physician Assessment of GAIS refers to the GAIS score evaluated by the physician. Change from Baseline in Physician Assessment of GAIS at Visit 3 is defined as the GAIS score assessed at Visit 3 in comparison to baseline.

Time frame:
Group A: baseline and week 4; Group B: baseline and week 8
Reported as:
Median · score on a scale
Change From Baseline in Physician Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 3
score on a scaleArm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between Treatments
Change From Baseline in Physician Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 33.5 (3.3 to 3.7)3.7 (3.3 to 3.9)
Statistical analysis
  • Arm A: 2-week Interval Between Treatments · Wilcoxon (Mann-Whitney) · p = 0.6961 (Statistical significance was defined as a p-value \< 0.05.) · Median difference (final values): -0.17Differece = (2-week interval group) - (4-week interval group)
SecondaryChange From Baseline in Patient Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 3

Global Aesthetic Improvement Score (GAIS) is a standardized 5-point scale used to assess overall aesthetic improvement following a cosmetic treatment. It ranges as follows: 5 - Very Much Improved, 4 - Much Improved, 3 - Improved, 2 - No Change, 1 - Worse Patient Assessment of GAIS refers to the GAIS score evaluated by the patient. Change from Baseline in Patient Assessment of GAIS at Visit 3 is defined as the GAIS score assessed at Visit 3 in comparison to baseline.

Time frame:
Group A: baseline and week 4; Group B: baseline and week 8
Reported as:
Median · score on a scale
Change From Baseline in Patient Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 3
score on a scaleArm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between Treatments
Change From Baseline in Patient Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 33.0 (3.0 to 3.0)2.0 (2.0 to 2.0)
Statistical analysis
  • Arm A: 2-week Interval Between Treatments vs Arm B: 4-week Interval Between Treatments · Wilcoxon (Mann-Whitney) · p = 0.0067 (Statistical significance was defined as a p-value \< 0.05.) · Median difference (final values): 1Differece = (2-week interval group) - (4-week interval group)
SecondaryVisual Analogue Scale (VAS) During Treatment

The visual analogue scale (VAS) is a psychometric response scale that can be used in questionnaires, which a higher score suggests greater pain intensity. It ranges from 0 to 10 in increments of 1. A score of 0 cm indicates "no pain" and 10 indicates "worst pain imaginable".

Time frame:
Group A: week 0; Group B: week 0
Reported as:
Median · score on a scale
Visual Analogue Scale (VAS) During Treatment
score on a scaleArm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between Treatments
Visual Analogue Scale (VAS) During Treatment5 (4 to 7)6.5 (3.5 to 7)

Adverse events

Collected over Arm A: 8 weeks, Arm B: 12 weeks. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Arm A: 2-week Interval Between Treatments0/10 (0%)0/10 (0%)1/10 (10%)
Arm B: 4-week Interval Between Treatments0/10 (0%)0/10 (0%)3/10 (30%)
Most frequent other events
Most frequent other events
EventArm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between Treatments
Severe swellingSkin and subcutaneous tissue disorders1/102/10
Severe tendernessSkin and subcutaneous tissue disorders0/102/10
Severe erythemaSkin and subcutaneous tissue disorders0/101/10
Severe itchinessSkin and subcutaneous tissue disorders0/101/10
Severe scalingSkin and subcutaneous tissue disorders0/101/10

Baseline characteristics

Age, Continuous
Age, Continuous(years)Arm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between TreatmentsTotal
Median53 (48 to 56.75)45 (44.25 to 47.5)48 (45 to 54.5)
Sex: Female, Male
Sex: Female, Male(Participants)Arm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between TreatmentsTotal
Female9918
Male112
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Arm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between TreatmentsTotal
American Indian or Alaska Native000
Asian101020
Native Hawaiian or Other Pacific Islander000
Black or African American000
White000
More than one race000
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(Participants)Arm A: 2-week Interval Between TreatmentsArm B: 4-week Interval Between TreatmentsTotal
Taiwan101020
08

Study locations

1 site
  • National Taiwan University Hospital
    Taipei, 100229, Taiwan
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Mar 10, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05811026
Lead sponsor
National Taiwan University Hospital
Collaborators
BRIDGECON CO,.LTD.
Responsible party
Sponsor
First posted
Apr 13, 2023
Start date
Mar 15, 2023
Primary completion
Jun 21, 2023
Completion
Dec 31, 2024
Results posted
Jun 18, 2025
Last update
Jun 18, 2025

Study contacts

Yi-Hua Liao, MD/PhD
study chair · National Taiwan University Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion